NASDAQ:PRVA Privia Health Group (PRVA) Stock Price, News & Analysis $22.79 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$22.58 -0.21 (-0.93%) As of 05/22/2026 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Privia Health Group Stock (NASDAQ:PRVA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Privia Health Group alerts:Sign Up Key Stats Today's Range$22.52▼$22.8550-Day Range$20.02▼$24.8552-Week Range$18.77▼$26.51Volume644,658 shsAverage Volume1.11 million shsMarket Capitalization$2.87 billionP/E Ratio142.45Dividend YieldN/APrice Target$31.23Consensus RatingModerate Buy Company Overview Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models. Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States. The company’s network encompasses employed and affiliated physicians in primary care and a range of specialties, enabling collaborative care delivery and streamlined administrative processes for more than 500,000 patients annually. Privia Health’s core offerings include care management services, performance analytics, patient engagement tools and revenue cycle management solutions. Its technology-enabled platform aggregates clinical and financial data in real time, helping physicians identify high-risk patients, track quality metrics and coordinate care across the continuum. By aligning incentives with payers and employers, Privia supports value-based arrangements that reward improved outcomes and cost efficiency. Co-founder and Chief Executive Officer Irad Kaufman leads Privia Health’s executive team, drawing on extensive experience in healthcare strategy and operations. Under his leadership, the company continues to expand its integrated network, deepen payer partnerships and refine its technology platform to meet evolving industry demands.AI Generated. May Contain Errors. Read More Privia Health Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks83rd Percentile Overall ScorePRVA MarketRank™: Privia Health Group scored higher than 83% of companies evaluated by MarketBeat, and ranked 103rd out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingPrivia Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on no strong buy ratings, 11 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialPrivia Health Group has a consensus price target of $31.23, representing about 37.0% upside from its current price of $22.79.Amount of Analyst CoveragePrivia Health Group has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Privia Health Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth46.88% Earnings GrowthEarnings for Privia Health Group are expected to grow by 46.88% in the coming year, from $0.32 to $0.47 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Privia Health Group is 142.45, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 43.13.Price to Earnings Ratio vs. SectorThe P/E ratio of Privia Health Group is 142.45, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 17.93.Price to Earnings Growth RatioPrivia Health Group has a PEG Ratio of 1.83. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrivia Health Group has a P/B Ratio of 3.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Privia Health Group's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.69% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 4.09.Change versus previous monthShort interest in Privia Health Group has recently increased by 18.32%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrivia Health Group does not currently pay a dividend.Dividend GrowthPrivia Health Group does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.76 News SentimentPrivia Health Group has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Privia Health Group this week, compared to 4 articles on an average week.Search Interest2 people have searched for PRVA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,107,491.00 in company stock.Percentage Held by Insiders5.70% of the stock of Privia Health Group is held by insiders.Percentage Held by Institutions94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Privia Health Group's insider trading history. Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRVA Stock News HeadlinesPrivia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of "Moderate Buy" from AnalystsMay 23 at 2:11 AM | americanbankingnews.comPrivia Health Stockholders Back Board, Pay, and AuditorMay 22 at 8:50 AM | tipranks.com$30 stock to buy before Starlink goes public (WATCH NOW!)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.May 25 at 1:00 AM | Paradigm Press (Ad)Privia Health Earnings Call Highlights Profitable GrowthMay 17, 2026 | theglobeandmail.comStatutory Profit Doesn't Reflect How Good Privia Health Group's (NASDAQ:PRVA) Earnings AreMay 14, 2026 | finance.yahoo.comDavid Mountcastle Sells 3,385 Shares of Privia Health Group (NASDAQ:PRVA) StockMay 14, 2026 | insidertrades.comPrivia Health Group, Inc. 2026 Q1 - Results - Earnings Call PresentationMay 9, 2026 | seekingalpha.comPrivia Health Group (NASDAQ:PRVA) Director Matthew Shawn Morris Sells 1,017 SharesMay 6, 2026 | insidertrades.comSee More Headlines PRVA Stock Analysis - Frequently Asked Questions How have PRVA shares performed this year? Privia Health Group's stock was trading at $23.71 at the beginning of 2026. Since then, PRVA stock has decreased by 3.9% and is now trading at $22.79. How were Privia Health Group's earnings last quarter? Privia Health Group, Inc. (NASDAQ:PRVA) announced its quarterly earnings data on Thursday, May, 7th. The company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.08 by $0.11. The firm's revenue for the quarter was up 25.8% compared to the same quarter last year. Read the conference call transcript. When did Privia Health Group IPO? Privia Health Group (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are Privia Health Group's major shareholders? Privia Health Group's top institutional shareholders include Van Berkom & Associates Inc. (3.23%), Riverbridge Partners LLC (3.12%), Bank of New York Mellon Corp (2.34%) and Principal Financial Group Inc. (2.17%). Insiders that own company stock include Adam Boehler, William M Sullivan, Parth Mehrotra, David Mountcastle, Thomas Bartrum, Edward C Fargis, Matthew Shawn Morris and Thomas A Mccarthy. View institutional ownership trends. How do I buy shares of Privia Health Group? Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Privia Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Privia Health Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST). Company Calendar Last Earnings5/07/2026Today5/25/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 PRVA's financial health is in the Green zone, according to TradeSmith. PRVA has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryHealthcare Current SymbolNASDAQ:PRVA CIK1759655 Webwww.priviahealth.com Phone571-366-8850FaxN/AEmployees1,226Year Founded2007Price Target and Rating Average Price Target for Privia Health Group$31.23 High Price Target$36.00 Low Price Target$25.00 Potential Upside/Downside+37.0%Consensus RatingModerate Buy Rating Score (0-4)2.79 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)$0.16 Trailing P/E Ratio142.45 Forward P/E Ratio71.22 P/E Growth1.83Net Income$22.92 million Net Margins0.97% Pretax Margin2.01% Return on Equity2.81% Return on Assets1.61% Debt Debt-to-Equity RatioN/A Current Ratio1.61 Quick Ratio1.61 Sales & Book Value Annual Sales$2.12 billion Price / Sales1.35 Cash Flow$0.27 per share Price / Cash Flow85.40 Book Value$6.40 per share Price / Book3.56Miscellaneous Outstanding Shares126,010,000Free Float118,829,000Market Cap$2.87 billion OptionableOptionable Beta0.96 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:PRVA) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
